DE2658938A1 - Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel - Google Patents

Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Info

Publication number
DE2658938A1
DE2658938A1 DE19762658938 DE2658938A DE2658938A1 DE 2658938 A1 DE2658938 A1 DE 2658938A1 DE 19762658938 DE19762658938 DE 19762658938 DE 2658938 A DE2658938 A DE 2658938A DE 2658938 A1 DE2658938 A1 DE 2658938A1
Authority
DE
Germany
Prior art keywords
formula
carbon atoms
group
compounds
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762658938
Other languages
German (de)
English (en)
Inventor
Carl Dr Cartheuser
Ulrich Dr Gebert
Heinz-Guenther Dr Greve
Jaromir Dr Komarek
Kurt Popendiker
Werner Dr Thorwart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Priority to DE19762658938 priority Critical patent/DE2658938A1/de
Priority to NL7714054A priority patent/NL7714054A/xx
Priority to ES465204A priority patent/ES465204A1/es
Priority to ZA00777586A priority patent/ZA777586B/xx
Priority to AU31811/77A priority patent/AU512353B2/en
Priority to GB53220/77A priority patent/GB1543517A/en
Priority to GR55042A priority patent/GR70042B/el
Priority to SE7714685A priority patent/SE7714685L/xx
Priority to IE2605/77A priority patent/IE46226B1/en
Priority to AT924777A priority patent/AT360544B/de
Priority to DK575277A priority patent/DK575277A/da
Priority to IL53674A priority patent/IL53674A/xx
Priority to PT67444A priority patent/PT67444B/pt
Priority to FI773903A priority patent/FI773903A7/fi
Priority to HU77HO2037A priority patent/HU177453B/hu
Priority to NO774456A priority patent/NO774456L/no
Priority to BE183831A priority patent/BE862303A/xx
Priority to LU78770A priority patent/LU78770A1/xx
Priority to IT31206/77A priority patent/IT1089233B/it
Priority to FR7739023A priority patent/FR2375225A1/fr
Priority to CA293,826A priority patent/CA1105933A/en
Priority to JP15547977A priority patent/JPS5379875A/ja
Priority to PL1977214671A priority patent/PL111792B1/pl
Priority to PL1977203359A priority patent/PL110753B1/pl
Priority to PL1977214670A priority patent/PL112153B1/pl
Priority to ES469456A priority patent/ES469456A1/es
Priority to ES469455A priority patent/ES469455A1/es
Publication of DE2658938A1 publication Critical patent/DE2658938A1/de
Priority to JP2205679A priority patent/JPS54141784A/ja
Priority to AT48180A priority patent/AT361000B/de
Priority to US06/150,705 priority patent/US4328227A/en
Priority to JP7845480A priority patent/JPS5695166A/ja
Priority to JP7845580A priority patent/JPS5677275A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/16—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Indole Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE19762658938 1976-12-24 1976-12-24 Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel Withdrawn DE2658938A1 (de)

Priority Applications (32)

Application Number Priority Date Filing Date Title
DE19762658938 DE2658938A1 (de) 1976-12-24 1976-12-24 Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
NL7714054A NL7714054A (nl) 1976-12-24 1977-12-19 Basisch gesubstitueerde o-propyloximen, werkwij- ze voor het bereiden daarvan en werkwijze voor het bereiden van een geneesmiddel met bloeddruk- verlagende werking.
ES465204A ES465204A1 (es) 1976-12-24 1977-12-19 Procedimiento para la produccion de 0-propiloximas sustitui-das con restos basicos.
ZA00777586A ZA777586B (en) 1976-12-24 1977-12-21 Novel o-propyloximes
AU31811/77A AU512353B2 (en) 1976-12-24 1977-12-21 Phenyl piperidine and phenyl piperazine derivatives
GB53220/77A GB1543517A (en) 1976-12-24 1977-12-21 O-propyl-oximes
GR55042A GR70042B (cg-RX-API-DMAC7.html) 1976-12-24 1977-12-22
SE7714685A SE7714685L (sv) 1976-12-24 1977-12-22 Forfarande for framstellning av nya basiskt substituerade o-propyloximer samt deras anvendning sasom lekemedel
IE2605/77A IE46226B1 (en) 1976-12-24 1977-12-22 Novel o-propyloximes
AT924777A AT360544B (de) 1976-12-24 1977-12-22 Verfahren zur herstellung von neuen piperazin- - und piperidinderivaten und ihren salzen
DK575277A DK575277A (da) 1976-12-24 1977-12-22 Fremgangsmaade til fremstilling af basisk substituerede 0-propyloximer
IL53674A IL53674A (en) 1976-12-24 1977-12-22 3-(4-phenylpiperazinyl or 4-phenylpiperidyl) o-propyloximes,their preparation and pharmaceutical compositions comprising them
PT67444A PT67444B (en) 1976-12-24 1977-12-22 A process for the preparation of novel basically substituted o-propyloximes and their use as pharmaceuticals
FI773903A FI773903A7 (fi) 1976-12-24 1977-12-22 Nya basiskt substituerade 0-propyloximer foerfarande foer deras framstaellning och deras anvaendning som laekemedel
NO774456A NO774456L (no) 1976-12-24 1977-12-23 Fremgangsmaate til fremstilling av nye basisk substituerte o-propyloksimer og deres anvendelse som legemiddel
HU77HO2037A HU177453B (en) 1976-12-24 1977-12-23 Process for preparing new basic substituted o-propyloximes and pharmaceutical preparations containing thereof
BE183831A BE862303A (fr) 1976-12-24 1977-12-23 Nouvelles 0-propyloximes substituees basiquement, leur procede de preparation et leur emploi comme medicaments
LU78770A LU78770A1 (cg-RX-API-DMAC7.html) 1976-12-24 1977-12-23
IT31206/77A IT1089233B (it) 1976-12-24 1977-12-23 O-propilossime sostituite con sostituenti basici,procedimento per la loro preparazione e loro impiego come prodotti medicinali
FR7739023A FR2375225A1 (fr) 1976-12-24 1977-12-23 Nouvelles o-propyloximes substituees basiquement, leur procede de preparation et leur emploi comme medicaments
CA293,826A CA1105933A (en) 1976-12-24 1977-12-23 O-propyloximes
JP15547977A JPS5379875A (en) 1976-12-24 1977-12-23 Basically substituted novel propyloxime process for preparing same and medical application thereof
PL1977203359A PL110753B1 (en) 1976-12-24 1977-12-24 Method of producing new basically substituted o-propyloximes
PL1977214671A PL111792B1 (en) 1976-12-24 1977-12-24 Method of manufacture of novel,base substituted o-propyloximes
PL1977214670A PL112153B1 (en) 1976-12-24 1977-12-24 Method of manufacture of novel base substituted o-propyloximes
ES469456A ES469456A1 (es) 1976-12-24 1978-05-04 Procedimiento para la produccion de o-propiloximas sustitui-das con restos basicos.
ES469455A ES469455A1 (es) 1976-12-24 1978-05-04 Procedimiento para la produccion de o-propiloximas sustitui-das con restos basicos.
JP2205679A JPS54141784A (en) 1976-12-24 1979-02-28 Novel basically substituted oopropyloxime* its manufacture and its use as medicine
AT48180A AT361000B (de) 1976-12-24 1980-01-30 Verfahren zur herstellung von neuen piperazin- - und piperidinderivaten und ihren salzen
US06/150,705 US4328227A (en) 1976-12-24 1980-05-19 Novel O-propyloximes
JP7845480A JPS5695166A (en) 1976-12-24 1980-06-12 Novel basically substituted oopropyloxime* its manufacture and its use as medicine
JP7845580A JPS5677275A (en) 1976-12-24 1980-06-12 Novel basically substituted oopropyloxime* its manufacture and its use as medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762658938 DE2658938A1 (de) 1976-12-24 1976-12-24 Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
DE2658938A1 true DE2658938A1 (de) 1978-07-06

Family

ID=5996701

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762658938 Withdrawn DE2658938A1 (de) 1976-12-24 1976-12-24 Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Country Status (24)

Country Link
US (1) US4328227A (cg-RX-API-DMAC7.html)
JP (4) JPS5379875A (cg-RX-API-DMAC7.html)
AT (1) AT360544B (cg-RX-API-DMAC7.html)
AU (1) AU512353B2 (cg-RX-API-DMAC7.html)
BE (1) BE862303A (cg-RX-API-DMAC7.html)
CA (1) CA1105933A (cg-RX-API-DMAC7.html)
DE (1) DE2658938A1 (cg-RX-API-DMAC7.html)
DK (1) DK575277A (cg-RX-API-DMAC7.html)
ES (3) ES465204A1 (cg-RX-API-DMAC7.html)
FI (1) FI773903A7 (cg-RX-API-DMAC7.html)
FR (1) FR2375225A1 (cg-RX-API-DMAC7.html)
GB (1) GB1543517A (cg-RX-API-DMAC7.html)
GR (1) GR70042B (cg-RX-API-DMAC7.html)
HU (1) HU177453B (cg-RX-API-DMAC7.html)
IE (1) IE46226B1 (cg-RX-API-DMAC7.html)
IL (1) IL53674A (cg-RX-API-DMAC7.html)
IT (1) IT1089233B (cg-RX-API-DMAC7.html)
LU (1) LU78770A1 (cg-RX-API-DMAC7.html)
NL (1) NL7714054A (cg-RX-API-DMAC7.html)
NO (1) NO774456L (cg-RX-API-DMAC7.html)
PL (3) PL112153B1 (cg-RX-API-DMAC7.html)
PT (1) PT67444B (cg-RX-API-DMAC7.html)
SE (1) SE7714685L (cg-RX-API-DMAC7.html)
ZA (1) ZA777586B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617012A1 (de) * 1993-03-02 1994-09-28 BASF Aktiengesellschaft Beta-Hydroxyoximether und bei Raumtemperatur mit beta-Hydroxyoximethern vernetzbare Dispersionen oder Lösungen

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3704604A1 (de) * 1987-02-13 1988-08-25 Mack Chem Pharm Oximether von 2,6-dioxabicyclo(3.3.0)octanonen, herstellungsverfahren und anwendung als arzneimittel
HU212415B (en) * 1989-08-25 1996-06-28 Egyt Gyogyszervegyeszeti Gyar Process for producing new cyclic oxym derivatives and pharmaceutical compositions containing them as active components
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
KR100533431B1 (ko) * 1995-01-23 2006-05-03 다이이치 아스비오파마 가부시키가이샤 허혈성질환에기인하는증상의완화또는치료용약제및이에유용한화합물

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2832804A (en) * 1958-04-29 Production of i-aminoindan derivatives
US2712031A (en) * 1953-10-27 1955-06-28 Lasdon Foundation Inc Monosubstituted salicylaldehyde alkoximes
US3060177A (en) * 1957-11-11 1962-10-23 Ciba Geigy Corp O-(aminoalkyl)oxime derivatives of heterocyclic aldehydes and ketones
US3692835A (en) * 1967-04-05 1972-09-19 Jan Van Dijk Pharmacologically active amino-ethyl oximes
US3951983A (en) * 1970-11-10 1976-04-20 Pfizer Inc. Phenoxypropanolpiperazines
SE371193B (cg-RX-API-DMAC7.html) * 1972-03-24 1974-11-11 Kabi Ab
US3954763A (en) * 1972-04-10 1976-05-04 Synthelabo N-Metatrifluoromethylthiophenyl-piperazine
GB1415505A (en) * 1972-06-01 1975-11-26 Ici Ltd Alkanolamine derivatives
SE397088B (sv) * 1972-06-17 1977-10-17 Sumitomo Chemical Co Forfarande for framstellning av nya 2-propanolderivat
US4100282A (en) * 1972-12-23 1978-07-11 Boehringer Ingelheim Gmbh N-Aryl-N'-(phenyl- or phenoxy-alkyl)-piperazines and salts thereof
GB1437868A (en) * 1973-05-09 1976-06-03 Synthelabo Arylpiperazinoalkyl esters
US4207319A (en) * 1973-10-19 1980-06-10 Albert Rolland S.A. Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof
US3960956A (en) * 1974-11-21 1976-06-01 E. I. Du Pont De Nemours & Company Antidepressant 1,1a,6,10b-tetrahydrodibenzo(a,e)-cyclo-propa(c) cyclohepten-6-substituted oximes
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
DK149043C (da) * 1976-01-27 1986-05-26 Egyt Gyogyszervegyeszeti Gyar Analogifremgangsmaade til fremstilling af 2-benzal- eller 2-benzyl-1-(aminoalkoxyimino)-cykloalkaner eller salte eller kvaternaere ammoniumderivater deraf
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0617012A1 (de) * 1993-03-02 1994-09-28 BASF Aktiengesellschaft Beta-Hydroxyoximether und bei Raumtemperatur mit beta-Hydroxyoximethern vernetzbare Dispersionen oder Lösungen
US5527944A (en) * 1993-03-02 1996-06-18 Basf Aktiengesellschaft β-hydroxyoxime ethers and solutions or dispersions crosslinkable at room temperature with β-hydroxyoxime ethers

Also Published As

Publication number Publication date
JPS54141784A (en) 1979-11-05
ATA924777A (de) 1980-06-15
IE46226L (en) 1978-06-24
FR2375225A1 (fr) 1978-07-21
HU177453B (en) 1981-10-28
SE7714685L (sv) 1978-06-25
CA1105933A (en) 1981-07-28
IL53674A0 (en) 1978-03-10
ES465204A1 (es) 1978-09-16
NO774456L (no) 1978-06-27
IE46226B1 (en) 1983-04-06
IL53674A (en) 1981-10-30
PL112153B1 (en) 1980-09-30
AU3181177A (en) 1979-06-28
ES469455A1 (es) 1978-12-01
AU512353B2 (en) 1980-10-09
ZA777586B (en) 1978-11-29
US4328227A (en) 1982-05-04
FR2375225B1 (cg-RX-API-DMAC7.html) 1980-06-20
ES469456A1 (es) 1979-04-01
NL7714054A (nl) 1978-06-27
PT67444A (en) 1978-01-01
GB1543517A (en) 1979-04-04
DK575277A (da) 1978-06-25
PL111792B1 (en) 1980-09-30
FI773903A7 (fi) 1978-06-25
PL203359A1 (pl) 1978-10-23
IT1089233B (it) 1985-06-18
JPS5677275A (en) 1981-06-25
JPS5379875A (en) 1978-07-14
BE862303A (fr) 1978-06-23
PL110753B1 (en) 1980-07-31
AT360544B (de) 1981-01-12
JPS5695166A (en) 1981-08-01
PT67444B (en) 1979-09-20
LU78770A1 (cg-RX-API-DMAC7.html) 1978-07-11
GR70042B (cg-RX-API-DMAC7.html) 1982-07-26

Similar Documents

Publication Publication Date Title
EP0253327B1 (de) Neue Diphenylpropylamin-Derivate, ihre Herstellung sowie ihre pharmazeutische Verwendung
EP0175363A2 (de) 4, 5-Dihydro-3(2H)-pyridazinone, Verfahren zu ihrer Herstellung und ihre Verwendung
DD202152A5 (de) Verfahren zur herstellung von phenylpiperazinderivaten
EP0014951A2 (de) Heterocyclische Oxypropanolamin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2431178A1 (de) Piperazinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
EP0124067B1 (de) 2-(Aminoalkyl)-pyrrol-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2651083C2 (cg-RX-API-DMAC7.html)
DE69312567T2 (de) 2-Formylpyridin-Thiosemicarbazonderivate, ihre Herstellung und ihre Verwendung als Antitumor Mittel
EP0000220A1 (de) Dihydrouracile, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
EP0263480A1 (de) Tetrahydrochinolinderivate, ein Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Zubereitungen
DE2434951C3 (de) In 3-stellung basisch substituierte diphenylhydantoine
CH640227A5 (de) Aminoalkoxyphenyl-derivate.
EP0018360B1 (de) N-(5-Methoxybentofuran-2-ylcarbonyl)-N'-benzylpiperazin und Verfahren zu dessen Herstellung
DE2658938A1 (de) Neue basisch substituierte 0-propyloxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DD149893A5 (de) Fungizide mittel
EP0237916A2 (de) 1, 1-Disubstituierte Cyclopropanderivate, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Antimykotika oder als Zwischenprodukte
DE2364685C3 (de) Phenoxyäthylamine
DE3014813A1 (de) 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesaeure-derivate
EP0025864A1 (de) Tetrahydrochinolinderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Zubereitungen
DE2209467A1 (de) Derivate des 1-phenoxy-3-amino-propan2-ols und verfahren zu ihrer herstellung
DE2658762A1 (de) Neue o-alkylierte oxime, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE2330295A1 (de) Phenylketon-derivate, deren salze, verfahren zu deren herstellung und diese verbindungen enthaltende arzneipraeparate
DE2923817B1 (de) (3-Alkylamino-2-hydroxypropoxy)-furan-2-carbonsaeureanilide und deren physiologisch vertraegliche Saeureadditionssalze und Verfahren zu deren Herstellung sowie Arzneimittel mit einem Gehalt dieser Verbindungen
EP0158312B1 (de) 1-[Cyclohexyl]-3,4-di-[hydro]-isochinolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
CH646170A5 (de) Pyrazolo(1,5-c)chinazolinderivate und diese enthaltende arzneimittel.

Legal Events

Date Code Title Description
OAP Request for examination filed
OD Request for examination
8130 Withdrawal